Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States
- PMID: 24478500
- PMCID: PMC3911329
- DOI: 10.1128/JCM.02177-13
Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States
Abstract
We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laboratories with complete surveys, 51 (43%) reported using NAAT in 2011. Laboratories using NAAT had stricter rejection policies and increased positivity rates.
References
-
- Centers for Disease Control and Prevention 2012. Vital signs: preventing Clostridium difficile infections. MMWR Morb. Mortal. Wkly. Rep. 61:157–162 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical